Related Experiment Videos
[Staging and therapeutic options in local prostatic carcinoma].
F Stoffel1, T Forster, T C Gasser
1Clinica Urologica Universitaria Basilea Città e Campagna.
Annali Italiani Di Chirurgia
|February 29, 2000
Summary
Prostate specific antigen (PSA) screening has increased early-stage prostate cancer (PCa) detection. Treatment options for localized PCa include radical prostatectomy, watchful waiting for insignificant cancers, and irradiation, with varying outcomes.
Area of Science:
- Oncology
- Urology
Context:
- Widespread adoption of prostate specific antigen (PSA) testing and digital rectal examination (DRE) has shifted prostate cancer (PCa) diagnosis towards earlier, localized stages.
- This has led to a decrease in advanced regional and metastatic PCa diagnoses.
Purpose:
- To critically assess current prostate cancer (PCa) staging modalities.
- To analyze therapeutic options for locally defined PCa.
- To evaluate the efficacy of different treatment approaches.
Summary:
- Radical prostatectomy is preferred for intracapsular PCa (T1a-T2b N0 M0), while watchful waiting may be suitable for "insignificant" cancers.
- Irradiation outcomes are less predictable than radical surgery.
- Neoadjuvant treatment for locally advanced PCa may be less effective than previously thought, and adjuvant treatment efficacy is sometimes unclear.
Impact:
- Highlights the importance of accurate staging for effective PCa management.
- Provides insights into the comparative effectiveness of surgery, irradiation, and hormonal therapies.
- Informs clinical decision-making regarding treatment strategies for localized and advanced prostate cancer.